Strategic and scientific contributions of human challenge trials for vaccine development: facts versus fantasy (#101)
8:00 PM
Activation of the NLRP3 inflammasome by Hendra Virus C-protein (#105)
8:00 PM
Features of a novel sheep model of ALI/ARDS induced by pulmonary instillation of live Streptococcus pneumoniae (#107)
8:00 PM
Antimalarial compounds the 2-Anilino 4-Amino substituted quinazolines, are irresistible and promiscuous. (#109)
8:00 PM
An integrated atlas of innate immune cell responses to activating stimuli reveals time-, dose- and ligand-dependent axes of inflammation. (#111)
8:00 PM
Establishing human small intestinal monolayers to study EPEC infection (#113)
8:00 PM
Smith-specific TCR-Tregs successfully treat lupus nephritis in a humanised model of disease (#115)
8:00 PM
Treating influenza A exacerbations – the case for pirfenidone over glucocorticoids (#117)
8:00 PM
Clade-specific gastrointestinal microbiota modulates epithelial endoplasmic reticulum stress response (#119)
8:00 PM
Helicobacter pylori extracellular vesicles contain urease and catalase which promote bacterial survival (#121)
8:00 PM
Decoding resident immune cell communication (#123)
8:00 PM
Cumulative vaccine take of RV3-BB rotavirus vaccine observed in Indonesian infants regardless of histo-blood group antigen status (#125)
8:00 PM
The Helicobacter pylori virulence factor, Tipa, is carried by bacterial extracellular vesicles to the nuclear compartment of host cells. (#127)
8:00 PM
Mapping of critical dengue virus-host interactions by APEX proximity labelling to reveal future antiviral drug targets. (#129)
8:00 PM
Do anti-LPS antibodies to patient microbiota associate with worse outcomes in Crohn's disease? (#131)
8:00 PM
Characterising the role of NKG7 in CD4+ and CD8+ T cells during malaria (#133)
8:00 PM
Distribution of phenotypic antimicrobial resistance in the gastrointestinal microbiome. (#135)
8:00 PM
COVID-19 in Brazil: Antibody Fc-dependent Mechanisms in Natural and Vaccine-Induced Immunity (#137)
8:00 PM
Antibody Protection of Pseudomonas aeruginosa Isolates from Bloodstream Infections (#139)
8:00 PM
Developing a reproducible and defined protocol to differentiate human induced pluripotent stem cells into colon epithelium as a model to study colonic innate immunity and inflammatory and infectious diseases (#141)
8:00 PM
Defining the fine specificity of antibody responses to polymorphic and conserved epitopes of the lead malaria vaccine antigen: Plasmodium falciparum circumsporozoite protein (#143)
8:00 PM
Modulation of ICAM-1 on vaginal epithelial cells by a microbiome bioactive and HIV transmission (#145)
8:00 PM
Characterisation of the DNA associated with bacterial membrane vesicles from the human gut microbiota (#147)
8:00 PM
Exploiting rabies virus hijacking of neuronal synapse formation (#149)
8:00 PM
Molecular regulation of Clec9A-mediated damage recognition and antigen presentation in dendritic cells (#151)
8:00 PM
HIV-1 infected macrophages can be made susceptible to Antibody Dependent Cellular Cytotoxicity by small molecule CD4 mimetics (#153)
8:00 PM
Recall, breadth and longevity of humoral immunity following Omicron BA.1 and BA.2 breakthrough infection (#155)
8:00 PM
Temporal kinetics of functional antibody responses following naturally acquired Plasmodium vivax malaria infections (#159)
8:00 PM
The interaction between Dynamin 3 and Kelch 13 in Plasmodium falciparum (#161)
8:00 PM
Investigating the effects of short chain fatty acids on fungal pathogen host interactions (#163)
8:00 PM
Characterisation of an essential dynamin-like protein in the malaria parasite Plasmodium falciparum (#165)
8:00 PM
Trafficking of the RhopH complex in malaria parasites (#167)
8:00 PM
Targeting virus-STAT interactions to generate novel attenuated ‘live’ vaccines (#169)
8:00 PM
Development and evaluation of novel immunotherapeutics for EBV lymphomas in preclinical models (#171)
8:00 PM
Mouse GBP1 is detrimental for the host during Burkholderia thailandensis infection (#173)
8:00 PM
A novel approach to uncover cryptic cases of immunodeficiency (#175)
8:00 PM
Age, chorioamnionitis, and the innate immune system in preterm infants (#177)
8:00 PM
BCL-2 and BCL-XL dynamically regulate LPS-primed macrophage survival in the absence of BCL2A1 (#179)
8:00 PM
The role of gut macrophages in gut epithelial barrier formation (#181)
8:00 PM
Enhanced stability of the SARS CoV-2 spike glycoprotein trimer following modification of an alanine cavity in the protein core (#183)
8:00 PM
The Plasmodium falciparum artemisinin resistance protein Kelch 13 is required for formation of normal cytostomes and parasite feeding (#185)
8:00 PM
Infectious Disease Research: It’s time to think differently (#187)
8:00 PM
Gasdermin D deficiency limits the severity of pulmonary disease during influenza A virus infection (#189)
8:00 PM
Lipid nanoparticle-mediated delivery of RNA therapeutics to treat Mycobacterium tuberculosis infection (#191)
8:00 PM
Streptococcus pneumoniae potently kill mesothelial and mesothelioma cells in a strain dependent manner (#193)
8:00 PM
The role of BTN3A1 in regulating αβ T cell responses (#195)
8:00 PM
Characterisation of CD1c-restricted T cells recognising mycobacterial lipids (#197)
8:00 PM
Understanding the innate immune response to Group A Streptococcus pili (#199)
8:00 PM
Single-cell RNAseq analysis of HIV reservoir cells from viremic and virally-suppressed individuals living with HIV (#201)
8:00 PM
MLKL deficiency protects against sterile inflammation and immunosenescence in aged mice (#203)
8:00 PM
Covalent probe reveals Ubc13 interactome in the malaria parasite (#205)
8:00 PM
Functional IL-37 receptor cell surface expression on immune cell subsets in health and disease by flow cytometry (#207)
8:00 PM
Structural and functional characterisation of a novel gasdermin protein (#209)
8:00 PM
Pilus tip protein AP1 essential for Group A Streptococcus adhesion to the tonsil epithelium (#211)
8:00 PM
Kinetics of the innate antiviral response of equine peripheral mononuclear cells in response to Ross River virus (#213)
8:00 PM